Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)

CNY 24.9

(-0.4%)

EBITDA Summary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s latest annual EBITDA in 2023 was 5.55 Billion CNY , down -62.73% from previous year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 1.49 Billion CNY , up 17.62% from previous quarter.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported an annual EBITDA of 7.87 Billion CNY in 2022, up 14.33% from previous year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported an annual EBITDA of 7.05 Billion CNY in 2021, up 34.92% from previous year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported a quarterly EBITDA of 1.39 Billion CNY for 2024 Q1, up 413.31% from previous quarter.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported a quarterly EBITDA of 1.49 Billion CNY for 2024 Q3, up 17.62% from previous quarter.

Annual EBITDA Chart of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2023 - 1995)

Historical Annual EBITDA of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2023 - 1995)

Year EBITDA EBITDA Growth
2023 5.55 Billion CNY -62.73%
2022 7.87 Billion CNY 14.33%
2021 7.05 Billion CNY 34.92%
2020 5.72 Billion CNY -12.58%
2019 7.07 Billion CNY 37.08%
2018 4.54 Billion CNY 3.48%
2017 4.26 Billion CNY 14.16%
2016 3.47 Billion CNY 6.61%
2015 3.43 Billion CNY 13.15%
2014 2.83 Billion CNY 8.08%
2013 2.36 Billion CNY 31.68%
2012 2 Billion CNY 17.02%
2011 2.25 Billion CNY 54.12%
2010 1.51 Billion CNY -56.09%
2009 3.53 Billion CNY 213.86%
2008 1.11 Billion CNY 11.17%
2007 1.02 Billion CNY 84.5%
2006 556.33 Million CNY 21.46%
2005 304.85 Million CNY 3.85%
2004 441.05 Million CNY -1.95%
2003 445.1 Million CNY 80.76%
2002 248.84 Million CNY 21.4%
2001 212.94 Million CNY 7.76%
2000 154.06 Million CNY 69.75%
1999 120.15 Million CNY 44.18%
1998 74.67 Million CNY 83.77%
1997 42.33 Million CNY 223.53%
1996 13.07 Million CNY 35.53%
1995 9.64 Million CNY 0.0%

Peer EBITDA Comparison of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Name EBITDA EBITDA Difference
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY -439.644%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY -16038.02%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY -4897.07%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY -2550.813%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY -3476.305%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 6223.324%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 9710.953%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY -4465.854%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY -1920.741%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY -472.055%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY -1319.065%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY -181.037%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY -53.688%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 2474.485%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -172027.504%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY -1985.248%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY -407.144%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY -2865.96%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY -1993.522%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY -1978.719%
KPC Pharmaceuticals, Inc. 801.81 Million CNY -593.351%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -31526.287%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY -1692.836%
Guobang Pharma Ltd. 1.04 Billion CNY -433.856%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY -2745.108%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY -1060.569%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY -442.706%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY -35.657%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY -654.808%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY -184.437%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY -935.811%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY -561.157%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY -21.957%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY -720.413%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 151366.452%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY -882.673%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY -777.913%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY -4872.258%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY -248.053%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -1540623.627%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY -649.359%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY -1072.116%
Changchun BCHT Biotechnology Co. 662.93 Million CNY -738.606%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY -2119.282%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY -389.26%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY -157.928%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY -803.793%
CanSino Biologics Inc. -1.64 Billion CNY 437.607%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY -2631.936%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY -648.069%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY -1803.652%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY -1465.711%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY -1493.654%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY -10.895%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY -266.341%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY -150.474%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY -371.022%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY -247.016%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 13.915%
China National Medicines Corporation Ltd. 2.82 Billion CNY -96.73%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY -2881.079%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY -561.808%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY -1597.473%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY -469.516%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY -2039.224%